Panzinorm, ntuziaka maka ojiji, contraindications na mmetụta

The ndabere maka ọgwụ "Panzinorm" bụ otu ìgwè nke enzymes secreted anyịnya nke na-anọchi anya lipase, amylase na protease. Ndị bekee na-e site na okike gbara na eriri afọ tract nke abụba, carbohydrates na-isi. A ọgwụ bụ Nchikota pancreatin dochie.
"Panzinorm", ntụziaka ezipụta maka ezughi oke mmepụta nke enzymes anyịnya, accelerates decomposition nke mgbagwoju ụmụ irighiri n'ime mfe iche-iche, eliminates digestive ọrịa. The Capsule dissolves ke afo. Na-pancreatin pellets nime ya na-echebe site a pụrụ iche shei acidic na gburugburu ebe obibi ha, ha, ha na gastric ọdịnaya a na-ebu n'ime duodenum, ebe onye Onyenwe anyị + bụ 5.5. E enzymes na-tọhapụrụ na-enye a nkịtị n'ahụ mgbaze.

"Panzinorm" ntụziaka na-egosi ime ihe emejuputara. Lipase mgbari abụba n'ime ọdụdụ asịd na glycerol, na-ekwe ha assimilation. N'otu aka ahụ lipase mkpatụ na abụba-soluble vitamin. Amylase atọghata carbohydrates n'ime dextrins, erekasịchaala ha n'ime glucose ụmụ irighiri. Protease mkpatụ na-edozi ana achi achi ha kewara n'ime ihe dị mfe bekee nke na-kpamkpam etinye obi gị dum na eriri afọ.

"Pancreatin" ukwuu mmemmem ọnọdụ nke ndị ọrịa na-adịghị ala ala pancreatitis, n'ihi na protease, nke bụ akụkụ nke ọgwụ, belata secretory ọrụ nke pancreas.

"Panzinorm" ntụziaka na-agba akaebe

"Pancreatin" na-kenyere ala ala pancreatic insufficiency dị iche iche si dị:
n'oge a na-adịghị ala pancreatitis;
mgbe ọrịa na-arịa mgbe ịwa ahụ, n'oge nke amanye a eriri afọ anastomosis;
na nchoputa nke cystic fibrosis;
na occlusion bile, pancreatic ducts.

"Panzinorm" ntụziaka egosi ndinọ mee ngwangwa e nkwalite nri site na eriri afọ:
imeju ọrịa;
na dyspepsia;
mgbe eji kegriiz ma ọ bụ roughage.
Tupu arụ radiographic na ultrasonic ọmụmụ iji ngwaahịa eliminates, haruru akwakọba na eriri afọ.
"Pancreatin" na-eji na flatulence.

The dọkịta na-ekpebi dose "pancreatin" n'otu n'otu. Dosed na nkà mmụta ọgwụ "Panzinorm", dabeere na ọrịa na-arịa, anyịnya, nri.

contraindications

The ọgwụ na-adịghị gosiri:
ma ọ bụrụ na ị na-hypersensitive ọ bụla mmiri na-eme ka ọgwụ,
nnukwu pancreatitis
ihe exacerbation nke ala ala pancreatitis iche-iche.

"Panzinorm" ndu mmetụta

Mgbe adakarị ọnwụnwa na-abịara adịkarịghị hụrụ nfụkasị ọkụ ọkụ ma ọ bụ itching.
Na obere okwu, ọ hụrụ a mebiri nke bronchi ọrụ.
Inweta nnukwu doses nke "panzinorm" nwere ike so ọgbụgbọ, vomiting, abdominal mgbu, afọ ntachi, afọ ọsịsa.

Ọ bụrụ na mbadamba nkume "Panzinorm" ọrịa na cystic fibrosis ga-na elu doses, n'ihi na ihe atụ, ego nke lipase ga-ihe karịrị 10 000 IU / kg / ụbọchị, e nwere ike a na ibelata nke lumen nke colon, mkpọchị ọrụ nke ileocecal eriri afọ, afọ.

Ngwa Notes "panzinorm"

Ọrịa onye ọnọdụ mgbe ingestion na-enyo enyo ihe mgbochi nke colon, ọ na-atụ aro iji leruo ewepu fibrosing colonopathy.

Clinical data na ojiji nke pancreatic enzymes na ụmụ nwaanyị dị ime na nwa ara na nne na bụghị. Ya mere, ọgwụgwọ nke "panzinorm" nyere ime na lactating nwanyi maka oké njọ mere na ẹkenịmde n'okpuru nlekọta nke a dibịa.

"Pancreatin" adịghị emetụta àgwà nke iga management, na-arụ ọrụ na n'ibu ngwaọrụ.
Maka ụmụaka ọgwụ na-kenyere dabeere na ogo nke ọrịa na nri.